Jubilant Pharmova has announced the board-approved re-appointment of its top leadership team. Mr. Priyavrat Bhartia continues as the Managing Director, and Mr. Arjun Shanker Bhartia continues as the Joint Managing Director. Both appointments are for a further period of three years, effective from June 1, 2026, subject to approval from the company’s shareholders.
Leadership Continuity
Following a recent board meeting held on May 22, 2026, the company has confirmed the extension of the terms for its executive leadership. The decision reflects the board’s confidence in the strategic direction and management capabilities demonstrated by both leaders. These re-appointments ensure continued stability in the administration and strategic growth of the organization.
Executive Profiles
Mr. Priyavrat Bhartia, who has served as Managing Director since June 2023, brings nearly 29 years of industry experience. With a strong academic background from Dartmouth College and Stanford University, he continues to drive the company’s long-term vision through strategic leadership and deep business acumen.
Mr. Arjun Shanker Bhartia, serving as Joint Managing Director since June 2023, has been instrumental in executing company strategy and managing operations. A graduate of Brown University, he possesses a strong understanding of industry dynamics and organizational performance, playing a vital role in the firm’s growth trajectory.
Future Outlook
Both executives will continue to oversee the overall management and administration of the company’s affairs. The Board remains confident that under their combined leadership and guidance, the company will continue to benefit from significant strategic insights and operational expertise over the next three-year term.
Source: BSE
